Memorial Sloan Kettering
See the following -
Experts Say IBM Watson’s Flaws are Rooted in Data Collection and Interoperability
Evan Sweeney | Fierce Healthcare | September 6, 2017
Despite being backed by a significant budget and the marketing power of a major technology company, IBM Watson appears to be falling short of expectations when it comes to revolutionizing cancer care. The shortcomings of IBM’s premier artificial intelligence system—made famous by its appearance on Jeopardy in 2011 and later co-pted to provide support for oncologists—are linked to a number of factors, according to an in-depth investigation by Stat that included interviews with doctors and artificial intelligence experts from around the world...
- Login to post comments